Document is current
Any future updates will be listed below
-
Authors
Sood, Ayushi
Peterson, Joshua
Jena, Jayashree
Challa, Vamsi
Washburn, Caden
Seeley, Randy J.
Pereira, Renata O. https://orcid.org/0000-0001-5809-4669
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK125405)
American Heart Association (25PRE1361334)
American Heart Association (25POST1377539)
National Institutes of Health (T32DK112751)
Roy J. Carver Charitable Trust (26-61640)
- License Information
-
More Information
Article History
Received: 3 November 2025
Revised: 24 March 2026
Accepted: 30 March 2026
First Online: 14 April 2026
Declarations
:
: All mouse experiments described in this study were conducted in accordance with NIH animal research guidelines and were approved by the University of Iowa IACUC.
: Not applicable.
: Not applicable.
: R.J.S. has received research support from Fractyl, Novo Nordisk, AstraZeneca, and Eli Lilly. R.J.S. has served on scientific advisory boards for Novo Nordisk, CinRX, Scohia, Fractyl and Structure Therapeutics. R.J.S. is a stakeholder of Calibrate and Rewind. All other authors have no competing interst to declare.
